Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleWithdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.AuthorsWebb, M J; Neth, Bryan J; Webb, Lauren M; Gompel, Jamie J Van; Link, Michael J; Neff, Brian A; Carlson, Matthew L; Driscoll, Colin L; Dornhoffer, Jim; Ruff, Michael W; Anderson, Kelsey A; Kizilbash, Sani H; Campian, Jian L; Uhm, Joon H; Lane, Jack I; Benson, John C; Blezek, Daniel J; Mehta, Parv M; Bathla, Girish; Sener, Ugur TPublicationNeuro-Oncology Advances, 2023, Vol 5, Issue 1, p1Publication typeArticleDOI10.1093/noajnl/vdad123